We are proud to announce that Specs has become a full partner in the upcoming Marie Sklodowska-Curie Actions (MSCA) Innovative Training Networks (ITN) MepAnti-project (Exploiting the methylerythritol phosphate pathway as a source of drug targets for novel anti-infectives). Within the interdisciplinary consortium of 11 academic and 6 non-academic partners there are 12 PhD positions available, one of which will be fulfilled at the Specs Research Laboratory. More information on the background of the project and how to apply can be found at https://lnkd.in/efvXdxi